Your browser doesn't support javascript.
loading
Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2.
Akashi, Yusaku; Kiyasu, Yoshihiko; Takeuchi, Yuto; Kato, Daisuke; Kuwahara, Miwa; Muramatsu, Shino; Ueda, Atsuo; Notake, Shigeyuki; Nakamura, Koji; Ishikawa, Hiroichi; Suzuki, Hiromichi.
Affiliation
  • Akashi Y; Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki, 3058558, Japan; Akashi Internal Medicine Clinic, 3-1-63 Asahigaoka, Kashiwara, Osaka, 5820026, Japan. Electronic address: yusaku-akashi@umin.ac.jp.
  • Kiyasu Y; Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki, 3058558, Japan; Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 3058576, Japan. Electronic address: kiyasu-tuk@umin.ac.jp.
  • Takeuchi Y; Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki, 3058558, Japan; Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 3058576, Japan. Electronic address: yuto-takeuchi@umin.ac.jp.
  • Kato D; Research & Development Division, Reagent R&D Department, Gosen site, Denka Co., Ltd., 1-2-2 Minamihoncho, Gosen-shi, Niigata, 9591695, Japan. Electronic address: daisuke-kato@denka.co.jp.
  • Kuwahara M; Research & Development Division, Reagent R&D Department, Gosen site, Denka Co., Ltd., 1-2-2 Minamihoncho, Gosen-shi, Niigata, 9591695, Japan. Electronic address: miwa-kuwahara@denka.co.jp.
  • Muramatsu S; Research & Development Division, Reagent R&D Department, Gosen site, Denka Co., Ltd., 1-2-2 Minamihoncho, Gosen-shi, Niigata, 9591695, Japan. Electronic address: shino-muramatsu@denka.co.jp.
  • Ueda A; Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 3058558, Japan. Electronic address: atsuo.ueda06090727@outlook.jp.
  • Notake S; Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 3058558, Japan. Electronic address: notake@tmch.or.jp.
  • Nakamura K; Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 3058558, Japan. Electronic address: koji-nakamura@tmch.or.jp.
  • Ishikawa H; Department of Respiratory Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 3058558, Japan. Electronic address: hishikawa@tmch.or.jp.
  • Suzuki H; Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki, 3058558, Japan; Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 3058576, Japan; Department of Infectious Diseases, Faculty of
J Infect Chemother ; 28(2): 248-251, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34799237
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Type: Article